a) UK
b) France
c) Germany
d) US
The United States has initiated the first human trial of COVID-19 vaccine in Seattle. The trial will be carried out on 45 healthy adult volunteers, aged between 18 to 55 years, across approximately 6 weeks. The first volunteer received the vaccine on March 16.